Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.

Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med (2012) 15.43

Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg (1980) 5.76

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol (2004) 2.22

Trends in esophageal adenocarcinoma incidence and mortality. Cancer (2012) 2.03

Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol (2004) 1.92

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer (2004) 1.75

Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69

Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg (1999) 1.42

Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer (2002) 1.28

Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med (2004) 1.04

Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach? World J Surg (2003) 0.96

The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol (2010) 0.93

Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study. Clin Radiol (2009) 0.93

Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg (2011) 0.93

Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition. Dis Esophagus (2010) 0.91

Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg (2009) 0.89

3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT. Strahlenther Onkol (2014) 0.87

Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer. Radiother Oncol (2014) 0.85

Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus: long-term outcome. Strahlenther Onkol (2014) 0.83

Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma. World J Surg (2015) 0.80

Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiother Oncol (2015) 0.78

18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making. PLoS One (2015) 0.78

Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus. Onco Targets Ther (2016) 0.76